Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Pharma and Consumer Health2.43B55.49%
Biologics1.95B44.56%
Inter-segment revenue elimination-2M-0.05%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.82B64.44%
Europe1.36B31.02%
Other356M8.13%
Elimination of revenue attributable to multiple locations-157M-3.58%
